Education
About Us
Working with TipRanks
Follow Us
Medrx Co., Ltd. (JP:4586)
:4586
Total Valuation
Medrx Co., Ltd. has a market cap or net worth of ¥6.06B. The enterprise value is ¥4.30B.
Market Cap¥6.06B
Enterprise Value¥4.30B
Share Statistics
Medrx Co., Ltd. has 59,365,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding59,365,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medrx Co., Ltd.’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -45.28%.
Return on Equity (ROE)-0.46
Return on Assets (ROA)-0.43
Return on Invested Capital (ROIC)-45.28%
Return on Capital Employed (ROCE)-0.45
Revenue Per Employee5.82M
Profits Per Employee-42.61M
Employee Count22
Asset Turnover0.06
Inventory Turnover0.89
Valuation Ratios
The current PE Ratio of Medrx Co., Ltd. is ―. Medrx Co., Ltd.’s PEG ratio is 1.04.
PE Ratio―
PS Ratio45.31
PB Ratio2.83
Price to Fair Value2.83
Price to FCF-5.98
Price to Operating Cash Flow0.00
PEG Ratio1.04
Income Statement
In the last 12 months, Medrx Co., Ltd. had revenue of 128.08M and earned -937.37M in profits. Earnings per share was -17.44.
Revenue128.08M
Gross Profit113.01M
Operating Income-942.00M
Pretax Income-925.05M
Net Income-937.37M
EBITDA-928.13M
Earnings Per Share (EPS)-17.44
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Medrx Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.49
52-Week Price Change20.00%
50-Day Moving Average113.50
200-Day Moving Average101.83
Relative Strength Index (RSI)33.87
Average Volume (3m)2.57M
Important Dates
Medrx Co., Ltd. upcoming earnings date is May 8, 2026, TBA (Confirmed).
Last Earnings DateFeb 13, 2026
Next Earnings DateMay 8, 2026
Ex-Dividend Date―
Financial Position
Medrx Co., Ltd. as a current ratio of 23.62, with Debt / Equity ratio of 0.00%
Current Ratio23.62
Quick Ratio23.40
Debt to Market Cap0.00
Net Debt to EBITDA1.89
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medrx Co., Ltd. has paid 12.32M in taxes.
Income Tax12.32M
Effective Tax Rate-0.01
Enterprise Valuation
Medrx Co., Ltd. EV to EBITDA ratio is -4.36, with an EV/FCF ratio of -4.17.
EV to Sales31.61
EV to EBITDA-4.36
EV to Free Cash Flow-4.17
EV to Operating Cash Flow-4.56
Balance Sheet
Medrx Co., Ltd. has ¥1.67B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of ¥1.67B billion.
Cash & Marketable Securities¥1.67B
Total Debt¥0.00
Net Cash¥1.67B
Net Cash Per Share¥28.09
Tangible Book Value Per Share¥38.13
Margins
Gross margin is 88.23%, with operating margin of -735.45%, and net profit margin of -731.84%.
Gross Margin88.23%
Operating Margin-735.45%
Pretax Margin-722.22%
Net Profit Margin-731.84%
EBITDA Margin-724.62%
EBIT Margin-735.45%
Analyst Forecast
The average price target for Medrx Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-52.41%
EPS Growth Forecast-80.31%